Forschung & Publikationen


Medizinische Promotionsarbeit mit erfolgreichem Abschluss am Krankenhaus Freudenstadt

Einfluss einer interventionellen Revaskularisierung auf die Entzündungskonstellation bei Patienten mit peripherer Verschlusskrankheit (pAVK)



An international, multicenter, randomized, double-blind, placebo-controlled Phase III trial investigating the efficacy and safety of rivaroxaban to reduce the risk of major thrombotic vascular events in patients with symptomatic peripheral artery disease undergoing lower extremity revascularization procedures


A prospective, multicenter Phase III study, confirming the superior effectiveness of the ELUVIA stent versus self-expanding Bare Nitinol Stents in the treatment of lesions in the femoropopliteal arteries.


A prospective, international, multi-center, single arm, non- interventional study to continue to assess the treatment by the Stellarex Balloon in superficial femoral and/or popliteal arteries according to the instructions for use in a broad, real-world, claudicant or ischemic rest pain patients population per the institution’s standard practice.




GDF-15 protects from macrophage accumulation in a mousemodel of advanced atherosclerosis

Eur J Med Res. 2013; 18: 19-25.
Michael R. Preusch, Matthias Baeuerle, Claudia Albrecht, Erwin Blessing, Marc Bischof, Hugo A Katus and Florian Bea
Universitätsklinik Heidelberg & Krankenhaus Freudenstadt


Ticagrelor Promotes Atherosclerotic Lesion Stabilization in advanced lesions of Apolipoprotein E Deficient Mice

Clin Res Cardiol 103, Suppl 1, April 2014
J. Rusnak, C. Mogler, A. Buttler, F. Bea, E. Blessing, H. A. Katus, M. R. Preusch 
Universitätsklinik Heidelberg and Krankenhaus Freudenstadt

Malignant pericardial effusion (MPE) - Sufficient treatment by radiotherapy.

Momm F1, Bea F2.

Author information

  • 1Ortenau-Klinikum Offenburg-Gengenbach, Teaching Hospital of the Albert-Ludwigs-University Freiburg, Department of Radiation Oncology, Germany. Electronic address:
  • 2Krankenhaus Freudenstadt, Teaching Hospital of the Eberhard-Karls-University Tübingen, Department of Cardiology, Germany.
  • Radiother Oncol. 2016; S0167: 34357-60.